nsc 350386 has been researched along with Leukemia L 1210 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rener, GA; Temple, C | 3 |
| Comber, RN; Rener, GA; Temple, C; Waud, WR | 1 |
| Comber, RN; Elliott, RD; Montgomery, JA; Rose, JD; Temple, C; Wheeler, GP | 1 |
5 other study(ies) available for nsc 350386 and Leukemia L 1210
| Article | Year |
|---|---|
Antimitotic agents: ring analogues and derivatives of ethyl [(S)-5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7- yl]carbamate.
Topics: Animals; Antineoplastic Agents; Cell Division; Cells, Cultured; Leukemia L1210; Pyrazines; Stereoisomerism; Structure-Activity Relationship; Urethane | 1992 |
Antimitotic agents. Chiral isomers of ethyl [5-amino-1,2-dihydro-3-(4-hydroxyphenyl)-2-methylpyrido[3,4-b]pyrazin-7 -yl]carbamate.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Leukemia L1210; Leukemia P388; Mice; Pyrazines; Stereoisomerism; Structure-Activity Relationship | 1992 |
Antimitotic agents. Alterations at the 2,3-positions of ethyl (5-amino-1,2-dihydropyrido[3,4-b]pyrazin-7-yl)carbamates.
Topics: Animals; Antineoplastic Agents; Carbamates; Leukemia L1210; Leukemia P388; Mice; Pyrazines; Structure-Activity Relationship | 1991 |
New anticancer agents: chiral isomers of ethyl 5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazine-7-car bamate .
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Colchicine; Drug Synergism; Isomerism; Leukemia L1210; Leukemia P388; Mice; Pyrazines; Structure-Activity Relationship; Tubulin; Vincristine | 1989 |
1,2-Dihydropyrido[3,4-b]pyrazines: structure-activity relationships.
Topics: Animals; Antineoplastic Agents; Cell Survival; Cells, Cultured; Leukemia L1210; Mice; Mitosis; Pyrazines; Pyridines; Structure-Activity Relationship | 1983 |